Catatonia: A syndrome to be remembered;Katatonie, een syndroom om te herinneren

Tijdschrift voor Psychiatrie

Volumn 47, Issue 6, 2005, Pages 371-382

  Van Harten, P N ^a,b  

^a A Opleiding van de Symfora Groep Gelokaliseerd   (Netherlands)

^b Symfora Groep   (Netherlands)

Author keywords

Catatonia; Diagnosis; Symptoms

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

AGITATION; CATALEPSY; CATATONIA; DEFENSE MECHANISM; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ELECTROCONVULSIVE THERAPY; HUMAN; MEDICAL LITERATURE; MENTAL DISEASE; MOOD DISORDER; MUTISM; NEUROLEPTIC MALIGNANT SYNDROME; PSYCHIATRIC DEPARTMENT; REVIEW; SCHIZOPHRENIA;

EID: 20744442441     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Akhtar, S., & Ahmad, H. (1993). Ciprofloxacin-induced catatonia. Journal of Clinical Psychiatry, 54, 115-116.
2. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4de versie). Washington, DC: American Psychiatric Press.
3. Berry, N., Sagar, R., & Tripathi, B.M. (2003). Catatonia and other psychiatric symptoms with vitamin B12 deficiency. Acta Psychiatrica Scandinavica, 108, 156-159.
4. Bleuler, E. (1916). Lehrbuch der Psychiatrie. Berlin: Julius Springer.
5. Braunig, P., Kruger, S., & Shugar, G. (1998). Prevalence and clinical significance of catatonic symptoms in mania. Comprehensive Psychiatry, 39, 35-46.
6. Braunig, P., Kruger, S., Shugar, G., e.a. (2000). The catatonia rating scale I-development, reliability, and use. Comprehensive Psychiatry, 41, 147-158.
7. Broek, W.W. van den. (2000). Richtlijn elektroconvulsietherapie. Amsterdam: Boom.
8. Bush, G., Fink, M., Petrides, G., e.a. (1996a). Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica, 93, 129-136.
9. Bush, G., Fink, M., Petrides, G., e.a. (1996b). Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatrica Scandinavica, 93, 137-143.
10. Bush, G., Petrides, G., & Francis, A. (1997). Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophrenia Research, 27, 83-92.
11. Castillo, E., Rubin, R.T., & Holsboer-Trachsler, E. (1989). Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 324-328.
12. Deuschle, M., & Lederbogen, F. (2001). Benzodiazepine withdrawal-induced catatonia. Pharmacopsychiatry, 34, 41-42.
13. Durrant, W. (1977). Catatonia after malaria. British Medical Journal, 2, 893.
14. Eede, F. van den, van Hecke, J., van den Bossche, B., e.a. (2003). Letale katatonie: de plaats van antipsychotica in de behandeling. Tijdschrift voor Psychiatrie, 45, 635-640.
15. Fink, M. (1991). Steroid-induced catatonia. British Journal of Psychiatry, 159, 445.
16. Fink, M., & Taylor, M.A. (2003). Catatonia: a clinician's guide to diagnosis, treatment, and neurology. Cambridge: Cambridge University Press.
17. Fisher, C.M. (1989). 'Catatonia' due to disulfiram toxicity. Archives of Neurology, 46, 798-804.
18. Francis, A., Divadeenam, K.M., Bush, G., e.a. (1997). Consistency of symptoms in recurrent catatonia. Comprehensive Psychiatry, 38, 56-60.
19. Franz, M., Gallhofer, B., & Kanzow, W.T. (1994). Treatment of catatonia with intravenous biperidene. British Journal of Psychiatry, 164, 847-848.
20. Gelenberg, A.J. (1976). The catatonic syndrome. Lancet, 1, 1339-1341.
21. Gelenberg, A.J. (1977). Criteria for the diagnosis of catatonia. American Journal of Psychiatry, 134, 462-463.
22. Gelenberg, A.J., & Mandel, M.R. (1977). Catatonic reactions to high-potency neuroleptic drugs. Archives of General Psychiatry, 34, 947-950.
23. Gingrich, J.A., Rudnick-Levin, F., Almeida, C., e.a. (1998). Cocaine and catatonia. American Journal of Psychiatry, 155, 1629.
24. Gjessing, L.R. (1974). A review of periodic catatonia. Biological Psychiatry, 8, 23-45.
25. Grisaru, N., Chudakov, B., Yaroslavsky, Y., e.a. (1998). Catatonia treated with transcranial magnetic stimulation. American Journal of Psychiatry, 155, 1630.
26. Guggenheim, F.G., & Babigian, H.M. (1974). Catatonic schizophrenia: epidemiology and clinical course. A 7-year register study of 798 cases. Journal of Nervous and Mental Disease, 158, 291-305.
27. Harten, P.N. van. (2000). Acute bewegingsstoornissen door antipsychotica. Neuropraxis, 4, 110-116.
28. Harten, P.N. van. (2003). Acute bewegingsstoornissen door medicijnen. Tijdschrift voor Psychiatrie, 45, 251-263.
29. Harten, P.N. van, & van Agtmael, M.A. (1995). Complete anticoagulation for treatment of neuroleptic malignant syndrome? American Journal of Psychiatry, 152, 1103-1104.
30. Hengeveld, M.W., & Schudel, W.J. (2003). Het psychiatrisch onderzoek. Utrecht: De Tijdstroom.
31. Hesslinger, B., Walden, J., & Normann, C. (2001). Acute and long-term treatment of catatonia with risperidone. Pharmacopsychiatry, 34, 25-26.
32. Jackson, C.W., Head, L.A., & Kellner, C.H. (1992). Catatonia associated with bupropion treatment. Journal of Clinical Psychiatry, 53, 210.
33. Johnson, J. (1993). Catatonia: the tension insanity. British Journal of Psychiatry, 162, 733-738.
34. Kahlbaum, K. (1874). Die Katatonie oder das Spannungsirresein: eine klinische psychischer Krankheit. Berlin
35. Kaiser, R., Konneker, M., Henneken, M., e.a. (2000). Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia. Molecular Psychiatry, 5, 418-424.
36. Knijff, D.W.W. de, van Est, M., Henrichs, J.H., e.a. (2004). Katatonie of maligne katatonie: een onderscheid met belangrijke consequenties. Tijdschrift voor Psychiatrie, 46, 323-327.
37. Kraepelin, E. (1919). Dementia praecox and paraphrenia (R.M. Barclay, Vert.). Huntington, NY: R.E. Krieger.
38. Lee, J.W. (1994). Catatonic stupor after 'ecstasy'. British Medical Journal, 308, 717-718.
39. Lee, J.W., Schwartz, D.L., & Hallmayer, J. (2000). Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Annals of Clinical Psychiatry, 12, 89-96.
40. Louis, E.D., & Pflaster, N.L. (1995). Catatonia mimicking nonconvulsive status epilepticus. Epilepsia, 36, 943-945.
41. Lund, C.E., Mortimer, A.M., Rogers, D., e.a. (1991). Motor, volitional and behavioural disorders in schizophrenia. 1: Assessment using the Modified Rogers Scale. British Journal of Psychiatry, 158, 323-327, 333-336.
42. Malur, C., Pasol, E., & Francis, A. (2001). ECT for prolonged catatonia. The Journal of ECT, 17, 55-59.
43. Mast, R.C. van der, Huyse, F.J., Droogleever Fortuijn, H.A., e.a. (2004). Richtlijn delirium. Amsterdam: Boom.
44. McCall, W.V., Mann, S.C., Shelp, F.E., e.a. (1995). Fatal pulmonary embolism in the catatonic syndrome: two case reports and a literature review. Journal of Clinical Psychiatry, 56, 21-25.
45. McCall, W.V., Shelp, F.E., & McDonald, W.M. (1992). Controlled investigation of the amobarbital interview for catatonic mutism. American Journal of Psychiatry, 149, 202-206.
46. Neumarker, K.J., Dudeck, U., & Plaza, P. (1989). Borrelien- Enzephalitis und Katatonie im Jugendalter: Ergebnisse und Kasuistik. Der Nervenarzt, 60, 115-119.
47. Northoff, G., Demisch, L., Wenke, J., e.a. (1996a). Plasma homovanillic acid concentrations in catatonia. Biological Psychiatry, 39, 436-443.
48. Northoff, G., Koch, A., Wenke, J., e.a. (1999). Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Movement Disorders, 14, 404-416.
49. Northoff, G., Krill, W., Wenke, J., e.a. (1996b). Subjektives Erleben in der Katatonie: Systematische Untersuchung bei 24 katatonen Patienten. Psychiatrische Praxis, 23, 69-73.
50. Northoff, G., Steinke, R., Nagel, D., e.a. (2000). Right lower prefrontoparietal cortical dysfunction in akinetic catatonia: a combined study of neuropsychology and regional cerebral blood flow. Psychological Medicine, 30, 583-596.
51. Otte, W., van den Broek, W.W., Birkenhäger, T.K., e.a. (1997). Het serotoninesyndroom: een literatuuroverzicht. Tijdschrift voor Psychiatrie, 39, 388-399.
52. Oulis, P., & Lykouras, L. (1996). Prevalence and diagnostic correlates of DSM-IV catatonic features among psychiatric inpatients. Journal of Nervous Mental Disease, 184, 378-379.
53. Peralta, V., & Cuesta, M.J. (2001). Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia. Schizophrenia Research, 47, 117-126.
54. Peralta, V., Cuesta, M.J., Mata, I., e.a. (1999). Serum iron in catatonic and noncatatonic psychotic patients. Biological Psychiatry, 45, 788-790.
55. Perera, K.M., Ferraro, A., & Pinto, M.R. (1995). Catatonia LSD induced? The Australian and New Zealand Journal of Psychiatry, 29, 324-327.
56. Petrides, G., Divadeenam, K.M., Bush, G., e.a. (1997). Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. Biological Psychiatry, 42, 375-381.
57. Rogers, D.M. (1992). Motor disorder in psychiatry: towards a neurological psychiatry. Chichester: John Wiley.
58. Rosebush, P.I., Hildebrand, A.M., Furlong, B.G., e.a. (1990). Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. Journal of Clinical Psychiatry, 51, 357-362.
59. Rosebush, P.I., MacQueen, G.M., & Mazurek, M.F. (1999). Catatonia following gabapentin withdrawal. Journal of Clinical Psychopharmacology, 19, 188-189.
60. Rosebush, P.I., & Mazurek, M.F. (1996). Catatonia after benzodiazepine withdrawal. Journal of Clinical Psychopharmacology, 16, 315-319.
61. Rosebush, P.I., & Mazurek, M.F. (1999). Catatonia: re-awakening to a forgotten disorder. Movement Disorders, 14, 395-397.
62. Schmider, J., Standhart, H., Deutschle, M., e.a. (1997). A double blind comparison of lorazepam and oxazepam in psychogenic catatonia. Xth Congress of the European College of Neuropsychopharmacology. Vienna, Austria, 13-17 september, 1997. Abstracts. European Neuropsychopharmacology, 7(Suppl. 2), S77-S306.
63. Sing, K.J., Ramaekers, G.M., & van Harten, P.N. (2002). Neuroleptic malignant syndrome and quetiapine. American Journal of Psychiatry, 159, 149-150.
64. Starkstein, S.E., Petracca, G., Teson, A., e.a. (1996). Catatonia in depression: prevalence, clinical correlates, and validation of a scale. Journal of Neurology, Neurosurgery, and Psychiatry, 60, 326-332.
65. Stober, G., Saar, K., Ruschendorf, F., e.a. (2000). Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15. American Journal of Human Genetics, 67, 1201-1207.
66. Taylor, M.A., & Abrams, R. (1977). Catatonia. Prevalence and importance in the manic phase of manic-depressive illness. Archives of General Psychiatry, 34, 1223-1225.
67. Taylor, M.A., & Fink, M. (2003). Catatonia in psychiatric classification: a home of its own. American Journal of Psychiatry, 160, 1233-1241.
68. Taylor, P., & Fleminger, J.J. (1980). ECT for schizophrenia. Lancet, 1, 1380-1382.
69. Thomas, P., Rascle, C., Mastain, B., e.a. (1997). Test for catatonia with zolpidem. Lancet, 349, 702.
70. Ungvari, G.S., Chiu, H.F., Chow, L.Y., e.a. (1999). Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology, 142, 393-398.
71. Ungvari, G.S., Kau, L.S., Wai-Kwong, T., e.a. (2001). The pharmacological treatment of catatonia: an overview. European Archives of Psychiatry and Clinical Neuroscience, 251(Suppl. 1), I31-I34.
72. Ungvari, G.S., Leung, C.M., Wong, M.K., e.a. (1994). Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatrica Scandinavica, 89, 285-288.
73. Weddingron, W.W., Jr., Marks, R.C., & Verghese, J.P. (1980). Disulfiram encephalopathy as a cause of the catatonia syndrome. American Journal of Psychiatry, 137, 1217-1219.
74. Widiger, T.A. (1994). DSM-IV sourcebook. Washington, DC: American Psychiatric Press.
75. Woods, S.W. (1980). Catatonia in a patient with subdural hematomas. American Journal of Psychiatry, 137, 983-984.